Regulatory Briefs: Contact Lenses; Circ Panel; Wheelchair Reclassification
This article was originally published in The Gray Sheet
Executive Summary
FDA has scheduled its ophthalmic panel to discuss expectations for contact lenses and accessories next month. Also, its circulatory devices panel will consider extracorporeal membrane oxygenation classification, and other devices. Finally, FDA has formally classified stair-climbing wheelchairs as class II with special controls.